CD19 and acute lymphoblastic leukemia: Similarly, CD19-directed CAR-T therapy has emerged as a promising treatment approach for R/R B-cell acute lymphoblastic leukemia (R/R B-ALL), demonstrating deep and durable responses in pediatric patients.